{"id":1106,"date":"2026-03-03T18:06:19","date_gmt":"2026-03-03T21:06:19","guid":{"rendered":"https:\/\/www.vitapharmaconsulting.com\/en\/?post_type=noticias&#038;p=1106"},"modified":"2026-03-03T18:06:19","modified_gmt":"2026-03-03T21:06:19","slug":"the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/","title":{"rendered":"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape"},"content":{"rendered":"<p><span style=\"color: #000000;\">Within the scope of the recent digital transformation initiatives led by the Brazilian Health Regulatory Agency (Anvisa), the issuance workflow for the Letter of Adequacy of the Active Pharmaceutical Ingredient Dossier (CADIFA) has undergone a significant update. The final stage of this service has migrated to a new internal system, resulting in a document with a renewed visual identity and automated data-filling processes.\u00a0<\/span><\/p>\n<p><span style=\"color: #000000;\">Although these changes are strictly administrative and visual\u2014without creating new regulatory or operational impacts for holders\u00a0\u2014\u00a0they reflect a continuous search for agility and the reduction of manual errors in API (Active Pharmaceutical Ingredient) management. This workflow optimization, however, is merely the most recent chapter in a trajectory that has profoundly altered how Brazil controls the quality of active substances.\u00a0<\/span><\/p>\n<p><span style=\"color: #000000;\" data-contrast=\"none\">To understand the scope of this digital simplification, it is essential to revisit the pillars sustaining CADIFA and the normative path that\u00a0established\u00a0this instrument in the country.<\/span><\/p>\n<p><span style=\"color: #000000;\"><strong><span class=\"TextRun SCXW153933541 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW153933541 BCX0\">CADIFA: rigor and Compliance<\/span><\/span><span class=\"EOP SCXW153933541 BCX0\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:360}\">\u00a0<\/span><\/strong><\/span><\/p>\n<p><span style=\"color: #000000;\">Established by <b>Collegiate<\/b>\u00a0<b>Board Resolution (RDC) No. 359\/2020<\/b>, CADIFA is the official document certifying that an Active Pharmaceutical Ingredient (API) is in full compliance with the Agency&#8217;s technical requirements. Unlike\u00a0previous\u00a0mechanisms, the Letter focuses on the adequacy of the Active Pharmaceutical Ingredient Dossier (DIFA), ensuring that the quality, safety, and efficacy of the substance have been meticulously evaluated.\u00a0<\/span><\/p>\n<p><span style=\"color: #000000;\">Currently, this document is mandatory for the registration and post-registration of synthetic and semi-synthetic\u00a0medicinal products, covering categories ranging from new\u00a0medicinal products\u00a0to generics\u00a0(unbranded)\u00a0and\u00a0similar products\u00a0(branded generics). Its importance lies in guaranteeing that the active principle\u2014whether imported or manufactured domestically\u2014strictly complies\u00a0with the specifications\u00a0required\u00a0for the Brazilian market.\u00a0<\/span><\/p>\n<p><span style=\"color: #000000;\"><b>History: from Individual control to international harmonization<\/b>\u00a0<\/span><\/p>\n<p><span style=\"color: #000000;\">The evolution of CADIFA in Brazil is marked by a transition from an\u00a0&#8220;individual registration&#8221; model to an &#8220;adequacy of dossier&#8221; system, bringing\u00a0Anvisa\u00a0closer to international standards, such as those of the European EDQM.\u00a0<\/span><\/p>\n<ol>\n<li aria-setsize=\"-1\" data-leveltext=\"%1.\" data-font=\"Calibri\" data-listid=\"45\" data-list-defn-props=\"{&quot;335552541&quot;:0,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769242&quot;:[65533,0],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;%1.&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span style=\"color: #000000;\"><b>The Pre-2020 Scenario:<\/b> until then, API control was primarily governed by RDC No. 57\/2009. The focus was on the registration of the ingredient, often\u00a0directly linked\u00a0to the registration of the finished\u00a0medicinal\u00a0product. This model generated duplicate technical analyses and lacked the agility required by global market updates.\u00a0<\/span><\/li>\n<\/ol>\n<ol>\n<li aria-setsize=\"-1\" data-leveltext=\"%1.\" data-font=\"Calibri\" data-listid=\"45\" data-list-defn-props=\"{&quot;335552541&quot;:0,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769242&quot;:[65533,0],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;%1.&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span style=\"color: #000000;\"><b>The 2020\u00a0Framework:<\/b> the implementation of RDCs No. 359, 361, and 362 in August 2020 shifted the paradigm. The creation of CADIFA introduced the concept of &#8220;shared use&#8221;,\u00a0allowing a single document to be\u00a0utilized\u00a0by multiple\u00a0medicinal product\u00a0manufacturers, thereby\u00a0optimizing\u00a0the product lifecycle and regulatory management.\u00a0<\/span><\/li>\n<\/ol>\n<ol>\n<li aria-setsize=\"-1\" data-leveltext=\"%1.\" data-font=\"Calibri\" data-listid=\"45\" data-list-defn-props=\"{&quot;335552541&quot;:0,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769242&quot;:[65533,0],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;%1.&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span style=\"color: #000000;\"><b>Consolidation and Efficiency (2021-2026):<\/b> following a transition period that ended in 2021, CADIFA became the mandatory pathway. Evolution continued with the publication of procedural manuals and, more recently, the implementation of\u00a0<b>Regulatory Reliance<\/b>\u00a0strategies, allowing\u00a0Anvisa\u00a0to\u00a0leverage\u00a0technical assessments from equivalent foreign authorities to accelerate issuance in Brazil.\u00a0<\/span><\/li>\n<\/ol>\n<p><span style=\"color: #000000;\"><b>Digital Transition<\/b><\/span><\/p>\n<p><span style=\"color: #000000;\">The implementation of the new CADIFA model in 2026, with its new visual identity and the signature repositioned at the end of the document (following Annex 1), crowns this maturation process. By automating information, the Agency not only gains\u00a0celerity\u00a0but also reinforces the transparency and standardization necessary for a predictable regulatory environment.\u00a0<\/span><\/p>\n<p><span style=\"color: #000000;\">For the regulated sector, the continuity of the application procedures via the\u00a0<i>Solicita<\/i>\u00a0system and the maintenance of the required technical content ensure that ongoing projects\u00a0proceed\u00a0under a more modern internal workflow.\u00a0<\/span><\/p>\n<p><span style=\"color: #000000;\">Recent procedural updates from\u00a0Anvisa\u00a0reflect a commitment to public service innovation and administrative efficiency. Monitoring this evolution requires attention to technical details and the maintenance of dossier compliance. For further information on how these workflows apply to your business model, our team of specialists is available for consultation.\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:360}\">\u00a0<\/span><\/p>\n","protected":false},"author":3,"featured_media":1107,"template":"","meta":{"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape - Vita<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape - Vita\" \/>\n<meta property=\"og:description\" content=\"Within the scope of the recent digital transformation initiatives led by the Brazilian Health Regulatory Agency (Anvisa), the issuance workflow for the Letter of Adequacy of the Active Pharmaceutical Ingredient Dossier (CADIFA) has undergone a significant update. The final stage of this service has migrated to a new internal system, resulting in a document with... Leia mais &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/03\/2010-blog-cadifa-2-1024x512.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/\",\"name\":\"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape - Vita\",\"isPartOf\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\"},\"datePublished\":\"2026-03-03T21:06:19+00:00\",\"dateModified\":\"2026-03-03T21:06:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs &amp; consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape - Vita","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/","og_locale":"pt_BR","og_type":"article","og_title":"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape - Vita","og_description":"Within the scope of the recent digital transformation initiatives led by the Brazilian Health Regulatory Agency (Anvisa), the issuance workflow for the Letter of Adequacy of the Active Pharmaceutical Ingredient Dossier (CADIFA) has undergone a significant update. The final stage of this service has migrated to a new internal system, resulting in a document with... Leia mais &raquo;","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/","og_site_name":"Vita","og_image":[{"width":1024,"height":512,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/03\/2010-blog-cadifa-2-1024x512.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/","name":"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape - Vita","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"datePublished":"2026-03-03T21:06:19+00:00","dateModified":"2026-03-03T21:06:19+00:00","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/03\/03\/the-digital-modernization-of-cadifa-and-its-evolution-in-the-brazilian-regulatory-landscape\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"The Digital Modernization of CADIFA and its Evolution in the Brazilian Regulatory Landscape"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs &amp; consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/1106"}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/3"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/1107"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=1106"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=1106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}